Urinary incontinence (UI) is a symptom. Patients seeking medical attention do so because of this symptom. As individuals’ views of bothersomeness vary significantly, the objective degree of symptom severity is less important than the patient’s overall outlook. Assessing well-being can be done by symptom evaluation, and general or condition-specific health-related quality of life questionnaire (HRQOL). Several studies using HRQOL questionnaires documented the negative effects of UI on the patient’s well-being, especially on daily activities and psychological distress. Generalised HRQOL instruments can be used but they may lack sensitivity to the characteristics of incontinence and its impact. Recently condition-specific UI questionnaires have been developed for a better assessment of specific issues and a greater sensitivity to changes after treatments. They reveal a substantial impact on everyday life,but a poor correlation was observed between the objective and subjective measurements. More useful short-form versions have recently been developed that meet many of the needs of therapists.

Keywords:
Urinary incontinence, Women, Quality of life, Questionnaire
This content is only available via PDF.
1997
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.